Laptaria cu Caimac has completed an IPO
Laptaria cu Caimac has raised US$5 million through a private placement of shares on the ATS Market of BSE. The funds will be used for the development of the factory, namely, the construction of a bottle and jar washing station, utility systems and packaging storage.
Laptaria cu Caimac was established in 1994 and was initially focused on agricultural activities, large crops (wheat, barley, rapeseed, triticale, corn, alfalfa and others, on an area of 3,000 ha, and a dairy farm (with over 2,700 animals). In 2018, it opened a modern dairy factory and launched Laptaria cu Caimac, a brand that has experienced rapid growth in popularity due to its high quality products. Laptaria cu Caimac has its own farm and uses the latest means to produce quality, natural, safe, nutritious dairy products without unnecessary additives. The modern processing plant has a technical processing capacity of around 75 tonnes of milk per day, and modern processing techniques that allow milk to be pasteurized at a lower-than-average temperature.
Oaklins’ team in Romania, in its role as authorized consultant, assisted Laptaria cu Caimac’s management team and shareholders all the way, from the start to the successful completion of the IPO. During this process, the team initiated and advised on many aspects, including, among others, securing cornerstone investors, deal structuring and the IPO pricing and sizing.
Adrian Cocan
CEO, Laptaria cu Caimac
Talk to the deal team
Related deals
Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreDuke Capital Limited has completed a fundraising
Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more